Akita Named a World’s Most Innovative Company for Profi Nasal Spray!
Read more

AKITA'S PLATFORM

Our advanced nasal spray platform enables rapid innovation—optimizing delivery, enhancing absorption, and extending effectiveness for better health.
Platform Page Banner

Nasal Science

Nose
The nose is the body's first line of defense against airborne threats and a highly efficient route for targeted delivery. The nasal mucosa filters the air we breathe, helping to block viruses and bacteria before they reach the lungs. It’s also highly vascularized, enabling rapid absorption while bypassing the GI tract and liver.
These advantages make the nose an ideal pathway for
preventative therapies and precision medicine.

Global Burden of Airborne Respiratory Infections

Respiratory infections wreak havoc on global health, causing millions of illnesses, hospitalizations, and widespread absenteeism in schools and workplaces each year, leading to significant economic and social impacts. Vulnerable populations—including children, the elderly, immunocompromised individuals, and those with chronic respiratory conditions—are at heightened risk of severe infections and complications. Many respiratory infections primarily spread through airborne transmission and target the nasal passages, making them particularly difficult to avoid. Environments such as schools, airplanes, nursing homes, and other crowded spaces present the greatest challenges for breaking the chain of transmission due to shared air, close contact, and prolonged exposure.
Nose

Backed by Science,
Verified by Research

Our nasal spray platform is backed by rigorous research, with its first
major application published in a top peer-reviewed journal.
A preclinical study in Advanced Materials (2024) highlights our Pathogen
Capture and Neutralizing Spray (PCANS), a drug-free formulation to block
and neutralize airborne viruses and bacteria.
Nasal Spray
  • Creates a Protective Barrier
– Forms a long-lasting gel-like coating.
  • Neutralizes 99.99% of influenza, SARS-CoV-2, RSV, and more.
  • Provides 8+ hours of protection
—far longer than standard nasal sprays.

  • Proven in Preclinical Studies – A single pre-exposure dose led to 99.99% viral reduction and 100% survival in a lethal flu model.

Our Proprietary
Platform

Our technology does more than just nasal delivery; it enables rapid onset, can control mucosal absorption, and optimize the residence time for nasal therapies.
Science Transformation
Time Wave

Functionality

  • Molecule encapsulation
  • Rapid onset
  • Reduces clearance
  • Transiently permeabilize nasal epithelium
  • Self administration

Features

  • Up to  ~150 kDa
  • 2 - 3 m onset
  • 3 - 24 h residence time
  • Able to deliver to
underlying cells
  • Strong safety profile

Applications

  • Respiratory infection prophylactic
  • Enhancing speed & extending release for large molecules
  • Nasal vaccines
  • Nose-to-brain delivery